NCT05516160

Brief Summary

The main objective of the project is to develop a new, more reliable method of modeling and parametrization of the halo and glare phenomena based on the subjective perception of these visual disturbances. The project will consist of three parts. The first will include the psychophysical measurement of glare and halo phenomena perceived by people with multifocal corrective lenses compared to the reference group. The second part will focus on the development of an algorithm for the generation of optical elements (masks) inducing standard halo and glow effects of a given size and intensity. The third phase of the project will concern the calibration of the developed algorithm. For this purpose, the halo and glare will be induced by the developed masks in the healthy eye, so as to match them with the vision disorders measured in the first part of the project in people using multifocal vision correction methods. As a result of this research, a scale for precise measurement of subjective halo and glare phenomena in the field of view will be created, independently covering their intensity and size, and in the future allowing for optical (and not graphic simulation as in commercially available simulators) simulation of scenes seen by patients.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2022

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 13, 2022

Completed
7 months until next milestone

First Posted

Study publicly available on registry

August 25, 2022

Completed
15 days until next milestone

Study Start

First participant enrolled

September 9, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 29, 2022

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2022

Completed
Last Updated

August 30, 2022

Status Verified

August 1, 2022

Enrollment Period

4 months

First QC Date

January 13, 2022

Last Update Submit

August 25, 2022

Conditions

Keywords

haloglareoptical aberrationsmultifocal lenses

Outcome Measures

Primary Outcomes (1)

  • presence of optical aberrations in analyzed eyes

    halo and glare presence in analyzed eyes

    up to 3 months

Study Arms (2)

multifocal lens

EXPERIMENTAL

examination of dysphotopsia

Diagnostic Test: diagnostic of optical aberrations

control group

ACTIVE COMPARATOR

examination of dysphotopsia

Diagnostic Test: diagnostic of optical aberrations

Interventions

diagnostic of optical aberrations with new device

control groupmultifocal lens

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult males and females, of any race
  • one or both eyes with implanted intraocular monofocal lens (10 eyes) and multifocal lens (10 eyes)
  • informed consent to participate in the study
  • presence at scheduled follow-up visits after the procedure for a period of 24 months.

You may not qualify if:

  • in the eye qualified for the test:
  • cataract
  • Fuchs dystrophy and other corneal diseases
  • evidence of serious eye disease
  • ophthalmic surgeries other than cataract surgery
  • clinically active or past uveitis
  • intraocular pressure (IOP) \>21 mmHg
  • glaucoma
  • retinal detachment or its suspicion in ultrasound examination of the eyeball
  • systemic diseases with ocular symptoms, including diseases that may affect the function of corneal endothelial cells
  • intolerance of the examination in the slit lamp or other procedures planned in the examination
  • pregnancy
  • mental disorders or emotional instability to an extent that does not allow the subject's informed consent in the study and presence at scheduled follow-up visits
  • documented sensitivity to pharmacological agents used in the study, i.e. topical anesthetics, fluorescein, other related to the ophthalmological examination serious fatal illnesses or a patient's medical condition preventing the study from continuing for a period of 6 months
  • current participation in other research programs
  • +5 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Song X, Liu X, Wang W, Zhu Y, Qin Z, Lyu D, Shentu X, Xv W, Chen P, Ke Y. Visual outcome and optical quality after implantation of zonal refractive multifocal and extended-range-of-vision IOLs: a prospective comparison. J Cataract Refract Surg. 2020 Apr;46(4):540-548. doi: 10.1097/j.jcrs.0000000000000088.

    PMID: 32213781BACKGROUND
  • Carson D, Lee S, Alexander E, Wei X, Lee S. Comparison of two laboratory-based systems for evaluation of halos in intraocular lenses. Clin Ophthalmol. 2018 Feb 21;12:385-393. doi: 10.2147/OPTH.S152201. eCollection 2018.

    PMID: 29503526BACKGROUND
  • Savini G, Schiano-Lomoriello D, Balducci N, Barboni P. Visual Performance of a New Extended Depth-of-Focus Intraocular Lens Compared to a Distance-Dominant Diffractive Multifocal Intraocular Lens. J Refract Surg. 2018 Apr 1;34(4):228-235. doi: 10.3928/1081597X-20180125-01.

    PMID: 29634837BACKGROUND

Study Officials

  • Karolina Krix-Jachym, MD PhD

    Military Institute of Warsaw, Poland

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Karolina Krix-Jachym, MD PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 13, 2022

First Posted

August 25, 2022

Study Start

September 9, 2022

Primary Completion

December 29, 2022

Study Completion

December 30, 2022

Last Updated

August 30, 2022

Record last verified: 2022-08